Covaxin works on Delta variant, 77.8% effective against symptomatic covid cases.
Additional clinical trials to establish safety and efficacy in children of 2-18 years of age are on. A clinical trial to determine the safety and immunogenicity of a booster dose is also in the process
Covaxin effective on Delta variant of Corona
You May Like
More From VOI
